These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34746132)

  • 21. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway.
    Li Y; Cheng X; Yan J; Jiang S
    Arch Med Sci; 2022; 18(1):183-194. PubMed ID: 35154539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
    Zhang J; Guo Y
    Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ID2 inhibits lung adenocarcinoma cell malignant behaviors by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway.
    Peng W; Chen J; He R; Tang Y; Jiang J; Li Y
    Tissue Cell; 2022 Dec; 79():101950. PubMed ID: 36274350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.
    Li Y; Zhou Y; Huang M; Wang Z; Liu D; Liu J; Fu X; Yang S; Shan S; Yang L; Guo Y; Ren P; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
    Cell Signal; 2023 Feb; 102():110553. PubMed ID: 36473621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
    Wang C; Yang X
    Int Immunopharmacol; 2024 Apr; 131():111613. PubMed ID: 38489970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway.
    Ma WQ; Miao MC; Ding PA; Tan BB; Liu WB; Guo S; Er LM; Zhang ZD; Zhao Q
    World J Gastrointest Oncol; 2024 Mar; 16(3):1029-1045. PubMed ID: 38577446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway.
    Wang Y; Li Y; Ran C; Le W; Dong J; Wang X; Chen B; Jiang X
    Neoplasma; 2023 Dec; 70(6):722-732. PubMed ID: 37962862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A/B.
    Zhang Q; Hao L; Shen Z; Wang F; Han C
    Environ Toxicol; 2021 Nov; 36(11):2174-2185. PubMed ID: 34291859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration.
    Chen JT; Hsu YL; Hsu YC; Tseng YH; Liu MH; Weng CW; Lin CH; Pan SH; Chen JJW; Wang CC
    Front Oncol; 2022; 12():801300. PubMed ID: 35982951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
    Zhang H; Xu W
    Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
    Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
    Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J; Wang M; Yang Y; Xing Y; Li S
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [No Abstract]   [Full Text] [Related]  

  • 40. RAB43 Promotes Gastric Cancer Cell Proliferation and Metastasis via Regulating the PI3K/AKT Signaling Pathway.
    Huang Z; Liang H; Chen L
    Onco Targets Ther; 2020; 13():2193-2202. PubMed ID: 32210585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.